Negatywne wyniki ostatnich badań nad aspiryną w prewencji pierwotnej – ASPREE, ASCEND, ARRIVE

Susan Jeffrey. ASPREE: No Benefit of Aspirin in Primary Prevention. Medscape (dostępny pełen tekst ang.)

“I think it’s been confusing to the public because people think that aspirin is good — and aspirin is good if you have heart disease, but if not, if you look at the summary of these three studies, at best, it’s neutral in terms of it has no benefit. At the worst, it obviously causes increased bleeding,” …

16 września 2018